One notable study has shown that cannabis can effectively alleviate chronic pain, including neuropathic pain and arthritis.

The study found that treatment with CBD significantly reduced the frequency of convulsive seizures in patients with Dravet syndrome.

Cannabis-based medications have been found to significantly reduce chemotherapy-induced nausea and vomiting in cancer patients.

Studies suggest that cannabis-based medications can help reduce muscle spasticity, pain, and urinary dysfunction associated with multiple sclerosis.

Some research indicates that cannabis may have anxiolytic and antidepressant properties, offering relief for individuals with anxiety disorders and depression.

Cannabis has been shown to lower intraocular pressure (IOP) in individuals with glaucoma, a condition characterized by increased pressure within the eye.

Preclinical studies, such as those reviewed in a paper published in Current Pharmaceutical Design, indicate that cannabinoids have neuroprotective properties.

Certain cannabis strains and cannabinoid compounds have been reported to improve sleep quality and duration in individuals with sleep disorders such as insomnia.

Cannabis has been shown to stimulate appetite in patients with HIV/AIDS and cancer, published in the American Journal of Hospice and Palliative Medicine.

Preliminary research, suggests that cannabis may improve symptoms and quality of life in patients with Crohn's disease and ulcerative colitis.

The study found that cannabis use was associated with significant improvements in cancer symptoms, including pain, nausea and vomiting.

Some studies suggest that cannabinoids, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), may have anti-inflammatory effects.